OZURDEX^® injection support resources:

Step-by-step injection guide

Download this digital guide to familiarise yourself with the steps to follow prior to, during and post-injection of OZURDEX^®.

Injection technique animation

Watch this short video to see an animated version of the OZURDEX^® injection procedure.

Patient counselling video

Hear top tips from Mr Al-Bermani, Consultant Ophthalmologist at the University Hospital of Wales, on how to put patients at ease before, during and after the OZURDEX^® injection procedure. 

DMO, diabetic macular oedema; RVO, retinal vein occlusion.

1. OZURDEX^®. Summary of Product Characteristics; 2. Garcia-Layana A, et al. Ophthalmologica. 2018;240:61–72.; 3. Wang K, et al.            Biol Pharm Bull. 2008;31:1541–6; 4. Rezar-Dreindl S, et al. Acta Ophthalmol. 2017;95:e119–27; 5. Edelman JL, et al. Exp Eye Res. 2005;80:249–58; 6. Tamura H, et al. Invest Ophthalmolo Vis Sci. 2005;46(4):1440–4; 7. Nehme A and Edelman J. Invest Ophthalmol Vis Sci. 2008;49:2030–8.

OZURDEX^® PRESCRIBING INFORMATION

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores.

Adverse events should also be reported to AbbVie on GBPV@abbvie.com